| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/15/2007 | US7217540 Polynucleotide encoding IL-1 zeta, TDZ.1 isoform polypeptide |
| 05/15/2007 | US7217539 Cell death inducers for mast cells |
| 05/15/2007 | US7217538 Nucleic acid molecule containing a nucleotide sequence encoding CaEss1 (candida albicans) gene or having at least 70% homology; antiproliferative application |
| 05/15/2007 | US7217535 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 05/15/2007 | US7217529 antibody binds to polypeptide which is a member of the chemokine family; diagnostic methods for detecting disorders related to the immune system |
| 05/15/2007 | US7217528 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/15/2007 | US7217526 identifying T cells in a sample that become activated in the presence of a vaccinia or variola virus using immunogenic mutant or fragment of peptide 165 as a CD8 T cell epitope |
| 05/15/2007 | US7217524 Method for diagnosing aplasia of corpus callosum |
| 05/15/2007 | US7217523 Nucleoside phosphoramidates and nucleoside phosphoramidases |
| 05/15/2007 | US7217517 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/15/2007 | US7217511 Methods of increasing antibiotic production in Streptomyces by deletion of the scbA gene |
| 05/15/2007 | US7217509 Isolating preferential polynucleotide sequences from library; obtain cellular chromatin, incubate with probe, fragment nucleotide sequences, recover marked polynucleotides |
| 05/15/2007 | US7217419 Vaccine for preventing cervical cancer |
| 05/15/2007 | US7217415 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase for therapeutic use |
| 05/15/2007 | US7217412 IL-17C related mammalian cytokine polypeptides |
| 05/15/2007 | US7217411 CeSERT genes, proteins, and modulatory compounds |
| 05/15/2007 | CA2515166C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 05/15/2007 | CA2394616C Gene cluster for ramoplanin biosynthesis |
| 05/15/2007 | CA2324649C Human p51 genes and gene products thereof |
| 05/15/2007 | CA2279919C Arthrobacter vaccine and its use against renibacterium salmoninarum |
| 05/15/2007 | CA2249736C Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2168885C Vaccine compositions |
| 05/15/2007 | CA2165672C Antibodies specific for human prostate glandular kallikrein |
| 05/15/2007 | CA2159822C Process for inhibiting the transcription of genes |
| 05/15/2007 | CA2155744C Preparation of nucleic acids using acid protease |
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/15/2007 | CA2149419C Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 05/15/2007 | CA2094705C Pharmaceutical composition for treating or preventing malign tumors |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/15/2007 | CA2071879C Glutamate receptor compositions and methods |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053850A2 Bone matrix compositions and methods |
| 05/10/2007 | WO2007053781A2 Compositions with antigens adsorbed to calcium phosphate |
| 05/10/2007 | WO2007053775A1 Novel activin receptor and uses thereof |
| 05/10/2007 | WO2007053637A2 A tumor susceptible rat with a mutation in apc gene |
| 05/10/2007 | WO2007053577A2 Compositions and methods for diagnosing and treating cancer |
| 05/10/2007 | WO2007053570A2 A polypeptide complex of trpm8 and calmodulin and its uses thereof |
| 05/10/2007 | WO2007052841A1 Platelet aggregation inhibitor composition |
| 05/10/2007 | WO2007052466A1 Method of screening substance useful in treating disease with the use of gpr40 and phospholipase |
| 05/10/2007 | WO2007052326A2 Method for conversion of uric acid to allantoin and related enzymes |
| 05/10/2007 | WO2007052238A2 Chimeric antigens and vaccines |
| 05/10/2007 | WO2007052067A2 Von willebrand factor (vwf) binding peptides |
| 05/10/2007 | WO2007052049A2 Crystal structure of cytochrome p450 and uses thereof |
| 05/10/2007 | WO2007052036A1 Conditionally-immortalised pancreatic cells |
| 05/10/2007 | WO2007052029A1 Oncolytic herpes virus vectors |
| 05/10/2007 | WO2007051987A1 Insulinotropic compounds and uses thereof |
| 05/10/2007 | WO2007051975A2 Compositions comprising igbpma and uses thereof |
| 05/10/2007 | WO2007051898A1 Alternative oxidase and uses thereof |
| 05/10/2007 | WO2007051781A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | WO2007051623A1 Affiphores, their isolation and use |
| 05/10/2007 | WO2007051577A2 METHOD FOR THE PRODUCTION OF γ-LINOLENIC ACID AND/OR STEARIDONIC ACID IN TRANSGENIC BRASSICACEAE AND LINACEAE |
| 05/10/2007 | WO2007051483A1 Disease resistant plants |
| 05/10/2007 | WO2007051355A1 The use of recombinant d-amino acid oxidase |
| 05/10/2007 | WO2007051317A1 Compositions and methods for treating atherosclerosis |
| 05/10/2007 | WO2007028845A3 Diagnostic kit and method for the quantitative determination of the expression of the maxi-k channel |
| 05/10/2007 | WO2007018463A3 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 05/10/2007 | WO2007017591A3 Guar extract-containing composition and se of a guar extract in the form of a surface treating and/or modifying agent |
| 05/10/2007 | WO2007017419A3 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 05/10/2007 | WO2007016938A3 Methods for diagnosing colon cancer and streptococcus bovis proteins for use in the method |
| 05/10/2007 | WO2007014971A3 Genes involved in the biosynthesis of thiocoraline and heterologous production of same |
| 05/10/2007 | WO2007002633A3 Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (plad) of tumor necrosis factor receptors |
| 05/10/2007 | WO2006131512A3 Anti-thrombotic agents |
| 05/10/2007 | WO2006083961A3 Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders |
| 05/10/2007 | WO2006049854A3 Disruptions of genes encoding secreted proteins, compositions and methods relating thereto |
| 05/10/2007 | WO2006031312A3 Compositions and treatments using ex vivo activated cells for myelosuppressed patients |
| 05/10/2007 | WO2006007124A3 Nucleic acid sequences encoding cel ii endonuclease |
| 05/10/2007 | WO2005037221A3 Cystatin c as an antagonist of tgf-b and methods related thereto |
| 05/10/2007 | WO2004060910A3 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 05/10/2007 | WO2003076567A3 Heterologous g-csf fusion proteins |
| 05/10/2007 | WO2002059274A3 Mosquito olfactory gene, polypeptides, and methods of use thereof |
| 05/10/2007 | WO2002051860A3 Synthetic peptide composition as immunogens for prevention of urinary tract infection |
| 05/10/2007 | WO2002010431A3 Functional biopolymer modification reagents and uses thereof |
| 05/10/2007 | US20070107084 Dof (DNA binding with one finger) sequences and methods of use |
| 05/10/2007 | US20070107079 Plant cell death system |
| 05/10/2007 | US20070107076 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 05/10/2007 | US20070107075 Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses Thereof |
| 05/10/2007 | US20070107070 Invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 05/10/2007 | US20070107069 Animal model having a chimeric human liver |
| 05/10/2007 | US20070106070 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell |
| 05/10/2007 | US20070106069 Non-Human Primate Fc Receptors and Methods of Use |
| 05/10/2007 | US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders |
| 05/10/2007 | US20070106067 Assay kit and antibody for human low molecular weight cd14 |
| 05/10/2007 | US20070106066 Cherkasky fusion proteins containing antibody-, antigen- and microtubule-binding regions and immune response-triggering regions |
| 05/10/2007 | US20070106065 TAT- 001 and methods of assessing and treating cancer |
| 05/10/2007 | US20070106064 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/10/2007 | US20070106063 Forms product with correctly linked cysteine bridges from an insulin precursor by enzymic cleavage by trypsin or a trypsin-like enzyme then folding process in the presence of cysteine or cysteine hydrochloride and a chaotropic auxiliary compound |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105794 Immunotherapy |
| 05/10/2007 | US20070105777 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/10/2007 | US20070105776 Inhibiting signaling by inhibiting palmitoylation; purified in presence of detergent to maintain solubility; maintenance and growth of stem cells, tissue regeneration |
| 05/10/2007 | US20070105773 Pharmaceutical composition comprising TrkAIg2 for use in the prevention and/or treatment of cancer |
| 05/10/2007 | US20070105771 Anti-CD26 antibodies and methods of use thereof |
| 05/10/2007 | US20070105770 Transglutaminase mediated conjugation of peptides |
| 05/10/2007 | US20070105767 Modulation of the interaction of muc1 with muc1 ligands |
| 05/10/2007 | US20070105765 Compositions comprising a fragment of the herpesviral protein vp22 for delivery of substances to cells |
| 05/10/2007 | US20070105764 Fusion protein for controlling production of proteins in bioreactor: cellular therapy (somatic gene therapy); antiviral therapies |
| 05/10/2007 | US20070105762 Non-activated polypeptides having a function of tissue regeneration and method for preparing the same |
| 05/10/2007 | US20070105754 Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition insecticide use of lectin KM+ to treat cicatrizations, use of lectin KM+ to prepare immunomodulating medicament, use of lectin KM+ to prepare anti-bacterial medicament, use lectin KM+ to prpare anti-viral medicament, use of lectin KM+ to prepare anti-parasite medicament, use of lectin KM+ to prepare anti-fungal medicament, use of lectin KM+ to prepare anti-parasite medicament expression method, DNA vector, recombinant |